1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Demographic, clinical, and lifestyle data on the observed groups of patients
Variables HIV+ Patients on cART HIV+ Therapy-Naïve Patients Healthy Controls P Value
No. 31 19 41 
Men (No.) (%) 28 (90.32) 17 (89.47) 37 (90.24) .98
Women (No.) (%) 3 (9.68) 2 (10.53) 4 (9.76) .98
Age (yr) 41.35 ± 9.66, 25–56 36.53 ± 8.15, 25–52 38.57 ± 6.97, 27–53 .09
Nicotine smoking (No.) (%) 11 (39.28) 8 (42.11) 17 (46.41) .43
Marijuana smoking (No.) (%) 2 (7.14) 1 (5.3) – –
Years of education^{^a} 10.84 ± 2.91, 4–16 11.79 ± 2.82, 4–17 12.72 ± 3.32, 4–18 .22
Self-reported infection duration^{^a} 6.44 ± 4.36, 1–16 6.26 ± 4.36, 1–15 – .89
Duration of cART (yr)^{^a} 5.1 ± 3.81, 1–16 – – –
Nadir CD4+ count (cells/μL)^{^a} 199.28 ± 140.134, 1–487 228.26 ± 145.29, 11–420 – .48
Current CD4+ count (cells/μL)^{^a} 620.28 ± 254.36, 147–1119 205.53 ± 192.91, 11–580 – <.001
CPE^{^a} 8.26 ± 0.89, 6–10 – – –
Note:— – indicates not applicable.
↵a All values are expressed as mean or minimum–maximum.